Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 26 entries
Sorted by: Best Match Show Resources per page
Perceptual and Social Attributes Underlining Age-Related Preferences for Faces.

Frontiers in human neuroscience

Kiiski HS, Cullen B, Clavin SL, Newell FN.
PMID: 27630553
Front Hum Neurosci. 2016 Aug 31;10:437. doi: 10.3389/fnhum.2016.00437. eCollection 2016.

Although aesthetic preferences are known to be important in person perception and can play a significant role in everyday social decisions, the effect of the age of the observer on aesthetic preferences for faces of different ages has not...

Cite
Kiiski HS, Cullen B, Clavin SL, et al. Perceptual and Social Attributes Underlining Age-Related Preferences for Faces. Front Hum Neurosci. 2016;10:437doi: 10.3389/fnhum.2016.00437.
Kiiski, H. S., Cullen, B., Clavin, S. L., & Newell, F. N. (2016). Perceptual and Social Attributes Underlining Age-Related Preferences for Faces. Frontiers in human neuroscience, 10437. https://doi.org/10.3389/fnhum.2016.00437
Kiiski, Hanni S M, et al. "Perceptual and Social Attributes Underlining Age-Related Preferences for Faces." Frontiers in human neuroscience vol. 10 (2016): 437. doi: https://doi.org/10.3389/fnhum.2016.00437
Kiiski HS, Cullen B, Clavin SL, Newell FN. Perceptual and Social Attributes Underlining Age-Related Preferences for Faces. Front Hum Neurosci. 2016 Aug 31;10:437. doi: 10.3389/fnhum.2016.00437. eCollection 2016. PMID: 27630553; PMCID: PMC5005962.
Copy Download .nbib Format: NLM
Formation of edge-sharing BO4 tetrahedra in the high-pressure borate HP-NiB2O4.

Angewandte Chemie (International ed. in English)

Knyrim JS, Roessner F, Jakob S, Johrendt D, Kinski I, Glaum R, Huppertz H.
PMID: 17943946
Angew Chem Int Ed Engl. 2007;46(47):9097-100. doi: 10.1002/anie.200703399.

No abstract available.

Cite
Knyrim JS, Roessner F, Jakob S, et al. Formation of edge-sharing BO4 tetrahedra in the high-pressure borate HP-NiB2O4. Angew Chem Int Ed Engl. 2007;46(47):9097-100doi: 10.1002/anie.200703399.
Knyrim, J. S., Roessner, F., Jakob, S., Johrendt, D., Kinski, I., Glaum, R., & Huppertz, H. (2007). Formation of edge-sharing BO4 tetrahedra in the high-pressure borate HP-NiB2O4. Angewandte Chemie (International ed. in English), 46(47), 9097-100. https://doi.org/10.1002/anie.200703399
Knyrim, Johanna S, et al. "Formation of edge-sharing BO4 tetrahedra in the high-pressure borate HP-NiB2O4." Angewandte Chemie (International ed. in English) vol. 46,47 (2007): 9097-100. doi: https://doi.org/10.1002/anie.200703399
Knyrim JS, Roessner F, Jakob S, Johrendt D, Kinski I, Glaum R, Huppertz H. Formation of edge-sharing BO4 tetrahedra in the high-pressure borate HP-NiB2O4. Angew Chem Int Ed Engl. 2007;46(47):9097-100. doi: 10.1002/anie.200703399. PMID: 17943946.
Copy Download .nbib Format: NLM
Time-courses of plasma IL-6 and HMGB-1 reflect initial severity of clinical presentation but do not predict poor neurologic outcome following subarachnoid hemorrhage.

eNeurologicalSci

Kiiski H, Långsjö J, Tenhunen J, Ala-Peijari M, Huhtala H, Hämäläinen M, Moilanen E, Öhman J, Peltola J.
PMID: 29260012
eNeurologicalSci. 2016 Dec 02;6:55-62. doi: 10.1016/j.ensci.2016.11.010. eCollection 2017 Mar.

OBJECTIVE: Patients with aneurysmal subarachnoid hemorrhage (aSAH) experience high mortality and morbidity. Neuroinflammation causes brain damage expansion after aSAH. Due to the complexity of the inflammatory response multiple biomarkers are needed to evaluate its' progression. We studied inflammatory process...

Cite
Kiiski H, Långsjö J, Tenhunen J, et al. Time-courses of plasma IL-6 and HMGB-1 reflect initial severity of clinical presentation but do not predict poor neurologic outcome following subarachnoid hemorrhage. eNeurologicalSci. 2016;6:55-62doi: 10.1016/j.ensci.2016.11.010.
Kiiski, H., Långsjö, J., Tenhunen, J., Ala-Peijari, M., Huhtala, H., Hämäläinen, M., Moilanen, E., Öhman, J., & Peltola, J. (2017). Time-courses of plasma IL-6 and HMGB-1 reflect initial severity of clinical presentation but do not predict poor neurologic outcome following subarachnoid hemorrhage. eNeurologicalSci, 655-62. https://doi.org/10.1016/j.ensci.2016.11.010
Kiiski, Heikki, et al. "Time-courses of plasma IL-6 and HMGB-1 reflect initial severity of clinical presentation but do not predict poor neurologic outcome following subarachnoid hemorrhage." eNeurologicalSci vol. 6 (2017): 55-62. doi: https://doi.org/10.1016/j.ensci.2016.11.010
Kiiski H, Långsjö J, Tenhunen J, Ala-Peijari M, Huhtala H, Hämäläinen M, Moilanen E, Öhman J, Peltola J. Time-courses of plasma IL-6 and HMGB-1 reflect initial severity of clinical presentation but do not predict poor neurologic outcome following subarachnoid hemorrhage. eNeurologicalSci. 2016 Dec 02;6:55-62. doi: 10.1016/j.ensci.2016.11.010. eCollection 2017 Mar. PMID: 29260012; PMCID: PMC5721561.
Copy Download .nbib Format: NLM
Mortality prediction in intensive care units including premorbid functional status improved performance and internal validity.

Journal of clinical epidemiology

Moser A, Reinikainen M, Jakob SM, Selander T, Pettilä V, Kiiski O, Varpula T, Raj R, Takala J.
PMID: 34823021
J Clin Epidemiol. 2021 Nov 22; doi: 10.1016/j.jclinepi.2021.11.028. Epub 2021 Nov 22.

OBJECTIVE: Prognostic models are key for benchmarking intensive care units (ICUs). They require up-to-date predictors and should report transportability properties for reliable predictions. We developed and validated an in-hospital mortality risk prediction model to facilitate benchmarking, quality assurance, and...

Cite
Moser A, Reinikainen M, Jakob SM, et al. Mortality prediction in intensive care units including premorbid functional status improved performance and internal validity. J Clin Epidemiol. 2021;doi: 10.1016/j.jclinepi.2021.11.028.
Moser, A., Reinikainen, M., Jakob, S. M., Selander, T., Pettilä, V., Kiiski, O., Varpula, T., Raj, R., & Takala, J. (2021). Mortality prediction in intensive care units including premorbid functional status improved performance and internal validity. Journal of clinical epidemiology, . https://doi.org/10.1016/j.jclinepi.2021.11.028
Moser, André, et al. "Mortality prediction in intensive care units including premorbid functional status improved performance and internal validity." Journal of clinical epidemiology vol. (2021). doi: https://doi.org/10.1016/j.jclinepi.2021.11.028
Moser A, Reinikainen M, Jakob SM, Selander T, Pettilä V, Kiiski O, Varpula T, Raj R, Takala J. Mortality prediction in intensive care units including premorbid functional status improved performance and internal validity. J Clin Epidemiol. 2021 Nov 22; doi: 10.1016/j.jclinepi.2021.11.028. Epub 2021 Nov 22. PMID: 34823021.
Copy Download .nbib Format: NLM
Congenital asymmetric distal myopathy with hemifacial weakness caused by a heterozygous large de novo mosaic deletion in nebulin.

Neuromuscular disorders : NMD

Sagath L, Lehtokari VL, Välipakka S, Vihola A, Gardberg M, Hackman P, Pelin K, Jokela M, Kiiski K, Udd B, Wallgren-Pettersson C.
PMID: 33933294
Neuromuscul Disord. 2021 Jun;31(6):539-545. doi: 10.1016/j.nmd.2021.03.006. Epub 2021 Mar 23.

We report the first mosaic mutation, a deletion of exons 11-107, identified in the nebulin gene in a Finnish patient presenting with a predominantly distal congenital myopathy and asymmetric muscle weakness. The female patient is ambulant and currently 26...

Cite
Sagath L, Lehtokari VL, Välipakka S, et al. Congenital asymmetric distal myopathy with hemifacial weakness caused by a heterozygous large de novo mosaic deletion in nebulin. Neuromuscul Disord. 2021;31(6):539-545doi: 10.1016/j.nmd.2021.03.006.
Sagath, L., Lehtokari, V. L., Välipakka, S., Vihola, A., Gardberg, M., Hackman, P., Pelin, K., Jokela, M., Kiiski, K., Udd, B., & Wallgren-Pettersson, C. (2021). Congenital asymmetric distal myopathy with hemifacial weakness caused by a heterozygous large de novo mosaic deletion in nebulin. Neuromuscular disorders : NMD, 31(6), 539-545. https://doi.org/10.1016/j.nmd.2021.03.006
Sagath, Lydia, et al. "Congenital asymmetric distal myopathy with hemifacial weakness caused by a heterozygous large de novo mosaic deletion in nebulin." Neuromuscular disorders : NMD vol. 31,6 (2021): 539-545. doi: https://doi.org/10.1016/j.nmd.2021.03.006
Sagath L, Lehtokari VL, Välipakka S, Vihola A, Gardberg M, Hackman P, Pelin K, Jokela M, Kiiski K, Udd B, Wallgren-Pettersson C. Congenital asymmetric distal myopathy with hemifacial weakness caused by a heterozygous large de novo mosaic deletion in nebulin. Neuromuscul Disord. 2021 Jun;31(6):539-545. doi: 10.1016/j.nmd.2021.03.006. Epub 2021 Mar 23. PMID: 33933294.
Copy Download .nbib Format: NLM
Author Correction: A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers.

Nature communications

Coignard J, Lush M, Beesley J, O'Mara TA, Dennis J, Tyrer JP, Barnes DR, McGuffog L, Leslie G, Bolla MK, Adank MA, Agata S, Ahearn T, Aittomäki K, Andrulis IL, Anton-Culver H, Arndt V, Arnold N, Aronson KJ, Arun BK, Augustinsson A, Azzollini J, Barrowdale D, Baynes C, Becher H, Bermisheva M, Bernstein L, Białkowska K, Blomqvist C, Bojesen SE, Bonanni B, Borg A, Brauch H, Brenner H, Burwinkel B, Buys SS, Caldés T, Caligo MA, Campa D, Carter BD, Castelao JE, Chang-Claude J, Chanock SJ, Chung WK, Claes KBM, Clarke CL, Collée JM, Conroy DM, Czene K, Daly MB, Devilee P, Diez O, Ding YC, Domchek SM, Dörk T, Dos-Santos-Silva I, Dunning AM, Dwek M, Eccles DM, Eliassen AH, Engel C, Eriksson M, Evans DG, Fasching PA, Flyger H, Fostira F, Friedman E, Fritschi L, Frost D, Gago-Dominguez M, Gapstur SM, Garber J, Garcia-Barberan V, García-Closas M, García-Sáenz JA, Gaudet MM, Gayther SA, Gehrig A, Georgoulias V, Giles GG, Godwin AK, Goldberg MS, Goldgar DE, González-Neira A, Greene MH, Guénel P, Haeberle L, Hahnen E, Haiman CA, Håkansson N, Hall P, Hamann U, Harrington PA, Hart SN, He W, Hogervorst FBL, Hollestelle A, Hopper JL, Horcasitas DJ, Hulick PJ, Hunter DJ, Imyanitov EN, Jager A, Jakubowska A, James PA, Jensen UB, John EM, Jones ME, Kaaks R, Kapoor PM, Karlan BY, Keeman R, Khusnutdinova E, Kiiski JI, Ko YD, Kosma VM, Kraft P, Kurian AW, Laitman Y, Lambrechts D, Le Marchand L, Lester J, Lesueur F, Lindstrom T, Lopez-Fernández A, Loud JT, Luccarini C, Mannermaa A, Manoukian S, Margolin S, Martens JWM, Mebirouk N, Meindl A, Miller A, Milne RL, Montagna M, Nathanson KL, Neuhausen SL, Nevanlinna H, Nielsen FC, O'Brien KM, Olopade OI, Olson JE, Olsson H, Osorio A, Ottini L, Park-Simon TW, Parsons MT, Pedersen IS, Peshkin B, Peterlongo P, Peto J, Pharoah PDP, Phillips KA, Polley EC, Poppe B, Presneau N, Pujana MA, Punie K, Radice P, Rantala J, Rashid MU, Rennert G, Rennert HS, Robson M, Romero A, Rossing M, Saloustros E, Sandler DP, Santella R, Scheuner MT, Schmidt MK, Schmidt G, Scott C, Sharma P, Soucy P, Southey MC, Spinelli JJ, Steinsnyder Z, Stone J, Stoppa-Lyonnet D, Swerdlow A, Tamimi RM, Tapper WJ, Taylor JA, Terry MB, Teulé A, Thull DL, Tischkowitz M, Toland AE, Torres D, Trainer AH, Truong T, Tung N, Vachon CM, Vega A, Vijai J, Wang Q, Wappenschmidt B, Weinberg CR, Weitzel JN, Wendt C, Wolk A, Yadav S, Yang XR, Yannoukakos D, Zheng W, Ziogas A, Zorn KK, Park SK, Thomassen M, Offit K, Schmutzler RK, Couch FJ, Simard J, Chenevix-Trench G, Easton DF, Andrieu N, Antoniou AC.
PMID: 33990587
Nat Commun. 2021 May 14;12(1):2986. doi: 10.1038/s41467-021-23162-4.

A Correction to this paper has been published: https://doi.org/10.1038/s41467-021-23162-4.

Cite
Coignard J, Lush M, Beesley J, et al. Author Correction: A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers. Nat Commun. 2021;12(1):2986doi: 10.1038/s41467-021-23162-4.
Coignard, J., Lush, M., Beesley, J., O'Mara, T. A., Dennis, J., Tyrer, J. P., Barnes, D. R., McGuffog, L., Leslie, G., Bolla, M. K., Adank, M. A., Agata, S., Ahearn, T., Aittomäki, K., Andrulis, I. L., Anton-Culver, H., Arndt, V., Arnold, N., Aronson, K. J., Arun, B. K., Augustinsson, A., Azzollini, J., Barrowdale, D., Baynes, C., Becher, H., Bermisheva, M., Bernstein, L., Białkowska, K., Blomqvist, C., Bojesen, S. E., Bonanni, B., Borg, A., Brauch, H., Brenner, H., Burwinkel, B., Buys, S. S., Caldés, T., Caligo, M. A., Campa, D., Carter, B. D., Castelao, J. E., Chang-Claude, J., Chanock, S. J., Chung, W. K., Claes, K. B. M., Clarke, C. L., Collée, J. M., Conroy, D. M., Czene, K., Daly, M. B., Devilee, P., Diez, O., Ding, Y. C., Domchek, S. M., Dörk, T., Dos-Santos-Silva, I., Dunning, A. M., Dwek, M., Eccles, D. M., Eliassen, A. H., Engel, C., Eriksson, M., Evans, D. G., Fasching, P. A., Flyger, H., Fostira, F., Friedman, E., Fritschi, L., Frost, D., Gago-Dominguez, M., Gapstur, S. M., Garber, J., Garcia-Barberan, V., García-Closas, M., García-Sáenz, J. A., Gaudet, M. M., Gayther, S. A., Gehrig, A., Georgoulias, V., Giles, G. G., Godwin, A. K., Goldberg, M. S., Goldgar, D. E., González-Neira, A., Greene, M. H., Guénel, P., Haeberle, L., Hahnen, E., Haiman, C. A., Håkansson, N., Hall, P., Hamann, U., Harrington, P. A., Hart, S. N., He, W., Hogervorst, F. B. L., Hollestelle, A., Hopper, J. L., Horcasitas, D. J., Hulick, P. J., Hunter, D. J., Imyanitov, E. N., Jager, A., Jakubowska, A., James, P. A., Jensen, U. B., John, E. M., Jones, M. E., Kaaks, R., Kapoor, P. M., Karlan, B. Y., Keeman, R., Khusnutdinova, E., Kiiski, J. I., Ko, Y. D., Kosma, V. M., Kraft, P., Kurian, A. W., Laitman, Y., Lambrechts, D., Le Marchand, L., Lester, J., Lesueur, F., Lindstrom, T., Lopez-Fernández, A., Loud, J. T., Luccarini, C., Mannermaa, A., Manoukian, S., Margolin, S., Martens, J. W. M., Mebirouk, N., Meindl, A., Miller, A., Milne, R. L., Montagna, M., Nathanson, K. L., Neuhausen, S. L., Nevanlinna, H., Nielsen, F. C., O'Brien, K. M., Olopade, O. I., Olson, J. E., Olsson, H., Osorio, A., Ottini, L., Park-Simon, T. W., Parsons, M. T., Pedersen, I. S., Peshkin, B., Peterlongo, P., Peto, J., Pharoah, P. D. P., Phillips, K. A., Polley, E. C., Poppe, B., Presneau, N., Pujana, M. A., Punie, K., Radice, P., Rantala, J., Rashid, M. U., Rennert, G., Rennert, H. S., Robson, M., Romero, A., Rossing, M., Saloustros, E., Sandler, D. P., Santella, R., Scheuner, M. T., Schmidt, M. K., Schmidt, G., Scott, C., Sharma, P., Soucy, P., Southey, M. C., Spinelli, J. J., Steinsnyder, Z., Stone, J., Stoppa-Lyonnet, D., Swerdlow, A., Tamimi, R. M., Tapper, W. J., Taylor, J. A., Terry, M. B., Teulé, A., Thull, D. L., Tischkowitz, M., Toland, A. E., Torres, D., Trainer, A. H., Truong, T., Tung, N., Vachon, C. M., Vega, A., Vijai, J., Wang, Q., Wappenschmidt, B., Weinberg, C. R., Weitzel, J. N., Wendt, C., Wolk, A., Yadav, S., Yang, X. R., Yannoukakos, D., Zheng, W., Ziogas, A., Zorn, K. K., Park, S. K., Thomassen, M., Offit, K., Schmutzler, R. K., Couch, F. J., Simard, J., Chenevix-Trench, G., Easton, D. F., Andrieu, N., & Antoniou, A. C. (2021). Author Correction: A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers. Nature communications, 12(1), 2986. https://doi.org/10.1038/s41467-021-23162-4
Coignard, Juliette, et al. "Author Correction: A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers." Nature communications vol. 12,1 (2021): 2986. doi: https://doi.org/10.1038/s41467-021-23162-4
Coignard J, Lush M, Beesley J, O'Mara TA, Dennis J, Tyrer JP, Barnes DR, McGuffog L, Leslie G, Bolla MK, Adank MA, Agata S, Ahearn T, Aittomäki K, Andrulis IL, Anton-Culver H, Arndt V, Arnold N, Aronson KJ, Arun BK, Augustinsson A, Azzollini J, Barrowdale D, Baynes C, Becher H, Bermisheva M, Bernstein L, Białkowska K, Blomqvist C, Bojesen SE, Bonanni B, Borg A, Brauch H, Brenner H, Burwinkel B, Buys SS, Caldés T, Caligo MA, Campa D, Carter BD, Castelao JE, Chang-Claude J, Chanock SJ, Chung WK, Claes KBM, Clarke CL, Collée JM, Conroy DM, Czene K, Daly MB, Devilee P, Diez O, Ding YC, Domchek SM, Dörk T, Dos-Santos-Silva I, Dunning AM, Dwek M, Eccles DM, Eliassen AH, Engel C, Eriksson M, Evans DG, Fasching PA, Flyger H, Fostira F, Friedman E, Fritschi L, Frost D, Gago-Dominguez M, Gapstur SM, Garber J, Garcia-Barberan V, García-Closas M, García-Sáenz JA, Gaudet MM, Gayther SA, Gehrig A, Georgoulias V, Giles GG, Godwin AK, Goldberg MS, Goldgar DE, González-Neira A, Greene MH, Guénel P, Haeberle L, Hahnen E, Haiman CA, Håkansson N, Hall P, Hamann U, Harrington PA, Hart SN, He W, Hogervorst FBL, Hollestelle A, Hopper JL, Horcasitas DJ, Hulick PJ, Hunter DJ, Imyanitov EN, Jager A, Jakubowska A, James PA, Jensen UB, John EM, Jones ME, Kaaks R, Kapoor PM, Karlan BY, Keeman R, Khusnutdinova E, Kiiski JI, Ko YD, Kosma VM, Kraft P, Kurian AW, Laitman Y, Lambrechts D, Le Marchand L, Lester J, Lesueur F, Lindstrom T, Lopez-Fernández A, Loud JT, Luccarini C, Mannermaa A, Manoukian S, Margolin S, Martens JWM, Mebirouk N, Meindl A, Miller A, Milne RL, Montagna M, Nathanson KL, Neuhausen SL, Nevanlinna H, Nielsen FC, O'Brien KM, Olopade OI, Olson JE, Olsson H, Osorio A, Ottini L, Park-Simon TW, Parsons MT, Pedersen IS, Peshkin B, Peterlongo P, Peto J, Pharoah PDP, Phillips KA, Polley EC, Poppe B, Presneau N, Pujana MA, Punie K, Radice P, Rantala J, Rashid MU, Rennert G, Rennert HS, Robson M, Romero A, Rossing M, Saloustros E, Sandler DP, Santella R, Scheuner MT, Schmidt MK, Schmidt G, Scott C, Sharma P, Soucy P, Southey MC, Spinelli JJ, Steinsnyder Z, Stone J, Stoppa-Lyonnet D, Swerdlow A, Tamimi RM, Tapper WJ, Taylor JA, Terry MB, Teulé A, Thull DL, Tischkowitz M, Toland AE, Torres D, Trainer AH, Truong T, Tung N, Vachon CM, Vega A, Vijai J, Wang Q, Wappenschmidt B, Weinberg CR, Weitzel JN, Wendt C, Wolk A, Yadav S, Yang XR, Yannoukakos D, Zheng W, Ziogas A, Zorn KK, Park SK, Thomassen M, Offit K, Schmutzler RK, Couch FJ, Simard J, Chenevix-Trench G, Easton DF, Andrieu N, Antoniou AC. Author Correction: A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers. Nat Commun. 2021 May 14;12(1):2986. doi: 10.1038/s41467-021-23162-4. PMID: 33990587; PMCID: PMC8121813.
Copy Download .nbib Format: NLM
Atopic dermatitis in adults: a population-based study in Finland.

International journal of dermatology

Kiiski V, Salava A, Susitaival P, Barnhill S, Remitz A, Heliovaara M.
PMID: 34510428
Int J Dermatol. 2021 Sep 12; doi: 10.1111/ijd.15912. Epub 2021 Sep 12.

BACKGROUND: The prevalence of atopic dermatitis (AD) has increased, but studies in adult or elderly populations are sparse.METHODS: We investigated 12-month and lifetime prevalences of AD in the Finnish adult population ≥30 years of age and analyzed living environment...

Cite
Kiiski V, Salava A, Susitaival P, et al. Atopic dermatitis in adults: a population-based study in Finland. Int J Dermatol. 2021;doi: 10.1111/ijd.15912.
Kiiski, V., Salava, A., Susitaival, P., Barnhill, S., Remitz, A., & Heliovaara, M. (2021). Atopic dermatitis in adults: a population-based study in Finland. International journal of dermatology, . https://doi.org/10.1111/ijd.15912
Kiiski, Ville, et al. "Atopic dermatitis in adults: a population-based study in Finland." International journal of dermatology vol. (2021). doi: https://doi.org/10.1111/ijd.15912
Kiiski V, Salava A, Susitaival P, Barnhill S, Remitz A, Heliovaara M. Atopic dermatitis in adults: a population-based study in Finland. Int J Dermatol. 2021 Sep 12; doi: 10.1111/ijd.15912. Epub 2021 Sep 12. PMID: 34510428.
Copy Download .nbib Format: NLM
Variation in severity-adjusted resource use and outcome in intensive care units.

Intensive care medicine

Takala J, Moser A, Raj R, Pettilä V, Irincheeva I, Selander T, Kiiski O, Varpula T, Reinikainen M, Jakob SM.
PMID: 34661693
Intensive Care Med. 2022 Jan;48(1):67-77. doi: 10.1007/s00134-021-06546-4. Epub 2021 Oct 18.

PURPOSE: Intensive care patients have increased risk of death and their care is expensive. We investigated whether risk-adjusted mortality and resources used to achieve survivors change over time and if their variation is associated with variables related to intensive...

Cite
Takala J, Moser A, Raj R, et al. Variation in severity-adjusted resource use and outcome in intensive care units. Intensive Care Med. 2021;48(1):67-77doi: 10.1007/s00134-021-06546-4.
Takala, J., Moser, A., Raj, R., Pettilä, V., Irincheeva, I., Selander, T., Kiiski, O., Varpula, T., Reinikainen, M., & Jakob, S. M. (2022). Variation in severity-adjusted resource use and outcome in intensive care units. Intensive care medicine, 48(1), 67-77. https://doi.org/10.1007/s00134-021-06546-4
Takala, Jukka, et al. "Variation in severity-adjusted resource use and outcome in intensive care units." Intensive care medicine vol. 48,1 (2022): 67-77. doi: https://doi.org/10.1007/s00134-021-06546-4
Takala J, Moser A, Raj R, Pettilä V, Irincheeva I, Selander T, Kiiski O, Varpula T, Reinikainen M, Jakob SM. Variation in severity-adjusted resource use and outcome in intensive care units. Intensive Care Med. 2022 Jan;48(1):67-77. doi: 10.1007/s00134-021-06546-4. Epub 2021 Oct 18. PMID: 34661693; PMCID: PMC8724095.
Copy Download .nbib Format: NLM
Measuring functional outcome in upper extremity soft-tissue sarcoma: Validation of the Toronto extremity salvage score and the QuickDASH patient-reported outcome instruments.

Journal of plastic, reconstructive & aesthetic surgery : JPRAS

Ketola H, Kask G, Barner-Rasmussen I, Tukiainen E, Blomqvist C, Laitinen MK, Kautiainen H, Kiiski J, Repo JP.
PMID: 34996722
J Plast Reconstr Aesthet Surg. 2021 Dec 01; doi: 10.1016/j.bjps.2021.11.081. Epub 2021 Dec 01.

Interest in functional outcome (FO) and health-related quality of life (HRQL) in extremity soft-tissue sarcoma (STS) patients has increased. The aim of this study was to validate two FO questionnaires for upper extremity STS patients: the Toronto Extremity Salvage...

Cite
Ketola H, Kask G, Barner-Rasmussen I, et al. Measuring functional outcome in upper extremity soft-tissue sarcoma: Validation of the Toronto extremity salvage score and the QuickDASH patient-reported outcome instruments. J Plast Reconstr Aesthet Surg. 2021;doi: 10.1016/j.bjps.2021.11.081.
Ketola, H., Kask, G., Barner-Rasmussen, I., Tukiainen, E., Blomqvist, C., Laitinen, M. K., Kautiainen, H., Kiiski, J., & Repo, J. P. (2021). Measuring functional outcome in upper extremity soft-tissue sarcoma: Validation of the Toronto extremity salvage score and the QuickDASH patient-reported outcome instruments. Journal of plastic, reconstructive & aesthetic surgery : JPRAS, . https://doi.org/10.1016/j.bjps.2021.11.081
Ketola, Helena, et al. "Measuring functional outcome in upper extremity soft-tissue sarcoma: Validation of the Toronto extremity salvage score and the QuickDASH patient-reported outcome instruments." Journal of plastic, reconstructive & aesthetic surgery : JPRAS vol. (2021). doi: https://doi.org/10.1016/j.bjps.2021.11.081
Ketola H, Kask G, Barner-Rasmussen I, Tukiainen E, Blomqvist C, Laitinen MK, Kautiainen H, Kiiski J, Repo JP. Measuring functional outcome in upper extremity soft-tissue sarcoma: Validation of the Toronto extremity salvage score and the QuickDASH patient-reported outcome instruments. J Plast Reconstr Aesthet Surg. 2021 Dec 01; doi: 10.1016/j.bjps.2021.11.081. Epub 2021 Dec 01. PMID: 34996722.
Copy Download .nbib Format: NLM
Healthy human CSF promotes glial differentiation of hESC-derived neural cells while retaining spontaneous activity in existing neuronal networks.

Biology open

Kiiski H, Aänismaa R, Tenhunen J, Hagman S, Ylä-Outinen L, Aho A, Yli-Hankala A, Bendel S, Skottman H, Narkilahti S.
PMID: 23789111
Biol Open. 2013 May 13;2(6):605-12. doi: 10.1242/bio.20134648. Print 2013 Jun 15.

The possibilities of human pluripotent stem cell-derived neural cells from the basic research tool to a treatment option in regenerative medicine have been well recognized. These cells also offer an interesting tool for in vitro models of neuronal networks...

Cite
Kiiski H, Aänismaa R, Tenhunen J, et al. Healthy human CSF promotes glial differentiation of hESC-derived neural cells while retaining spontaneous activity in existing neuronal networks. Biol Open. 2013;2(6):605-12doi: 10.1242/bio.20134648.
Kiiski, H., Aänismaa, R., Tenhunen, J., Hagman, S., Ylä-Outinen, L., Aho, A., Yli-Hankala, A., Bendel, S., Skottman, H., & Narkilahti, S. (2013). Healthy human CSF promotes glial differentiation of hESC-derived neural cells while retaining spontaneous activity in existing neuronal networks. Biology open, 2(6), 605-12. https://doi.org/10.1242/bio.20134648
Kiiski, Heikki, et al. "Healthy human CSF promotes glial differentiation of hESC-derived neural cells while retaining spontaneous activity in existing neuronal networks." Biology open vol. 2,6 (2013): 605-12. doi: https://doi.org/10.1242/bio.20134648
Kiiski H, Aänismaa R, Tenhunen J, Hagman S, Ylä-Outinen L, Aho A, Yli-Hankala A, Bendel S, Skottman H, Narkilahti S. Healthy human CSF promotes glial differentiation of hESC-derived neural cells while retaining spontaneous activity in existing neuronal networks. Biol Open. 2013 May 13;2(6):605-12. doi: 10.1242/bio.20134648. Print 2013 Jun 15. PMID: 23789111; PMCID: PMC3683163.
Copy Download .nbib Format: NLM
Treatment outcomes in women with idiopathic generalized epilepsy.

Acta neurologica Scandinavica

Kiiski R, Basnyat P, Raitanen J, Rainesalo S, Peltola J, Mäkinen J.
PMID: 34877648
Acta Neurol Scand. 2021 Dec 07; doi: 10.1111/ane.13567. Epub 2021 Dec 07.

OBJECTIVES: To evaluate the changes in prescription patterns in the treatment of idiopathic generalized epilepsy (IGE) due to updated treatment recommendations and to assess seizure outcomes of valproate compared to other antiseizure medications (ASMs), with emphasis on women with...

Cite
Kiiski R, Basnyat P, Raitanen J, et al. Treatment outcomes in women with idiopathic generalized epilepsy. Acta Neurol Scand. 2021;doi: 10.1111/ane.13567.
Kiiski, R., Basnyat, P., Raitanen, J., Rainesalo, S., Peltola, J., & Mäkinen, J. (2021). Treatment outcomes in women with idiopathic generalized epilepsy. Acta neurologica Scandinavica, . https://doi.org/10.1111/ane.13567
Kiiski, Rebecca, et al. "Treatment outcomes in women with idiopathic generalized epilepsy." Acta neurologica Scandinavica vol. (2021). doi: https://doi.org/10.1111/ane.13567
Kiiski R, Basnyat P, Raitanen J, Rainesalo S, Peltola J, Mäkinen J. Treatment outcomes in women with idiopathic generalized epilepsy. Acta Neurol Scand. 2021 Dec 07; doi: 10.1111/ane.13567. Epub 2021 Dec 07. PMID: 34877648.
Copy Download .nbib Format: NLM
A Large Deletion Affecting TPM3, Causing Severe Nemaline Myopathy.

Journal of neuromuscular diseases

Kiiski K, Lehtokari VL, Manzur AY, Sewry C, Zaharieva I, Muntoni F, Pelin K, Wallgren-Pettersson C.
PMID: 27858751
J Neuromuscul Dis. 2015 Sep 21;2(4):433-438. doi: 10.3233/JND-150107.

BACKGROUND AND OBJECTIVES: Nemaline myopathy may be caused by pathogenic variants in the TPM3 gene and is then called NEM1. All previously identified disease-causing variants are point mutations including missense, nonsense and splice-site variants. The aim of the study...

Cite
Kiiski K, Lehtokari VL, Manzur AY, et al. A Large Deletion Affecting TPM3, Causing Severe Nemaline Myopathy. J Neuromuscul Dis. 2015;2(4):433-438doi: 10.3233/JND-150107.
Kiiski, K., Lehtokari, V. L., Manzur, A. Y., Sewry, C., Zaharieva, I., Muntoni, F., Pelin, K., & Wallgren-Pettersson, C. (2015). A Large Deletion Affecting TPM3, Causing Severe Nemaline Myopathy. Journal of neuromuscular diseases, 2(4), 433-438. https://doi.org/10.3233/JND-150107
Kiiski, K, et al. "A Large Deletion Affecting TPM3, Causing Severe Nemaline Myopathy." Journal of neuromuscular diseases vol. 2,4 (2015): 433-438. doi: https://doi.org/10.3233/JND-150107
Kiiski K, Lehtokari VL, Manzur AY, Sewry C, Zaharieva I, Muntoni F, Pelin K, Wallgren-Pettersson C. A Large Deletion Affecting TPM3, Causing Severe Nemaline Myopathy. J Neuromuscul Dis. 2015 Sep 21;2(4):433-438. doi: 10.3233/JND-150107. PMID: 27858751; PMCID: PMC5240603.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 26 entries